ScholarLens Back to search
2009•ZhongchengyaoRequires access

The prophylactic effect of lumbrokinase plus aspirin on recurrence of ischemic stroke in the patients

Feng Ye

Open publisher page 0 citations

Abstract

AIM: To assess the prophylactic effect of lumbrokinase plus aspirin on recurrence of ischemic stroke in the patients recovering from cerebral infarction. METHODS: 87 patients of cerebral infarction were assigned to two groups:control and treatment group,treated respectively with aspirin in control group and lumbrokinase plus aspirin in the treatment group.The recurrence rate and clinical efficacy were analysed. RESULTS: There were remarkable differences in recurrence rate and clinical efficacy between the two groups(P0.05).The recurrence rate was(11.9%) in the control group and 4.4% in the treatment group.The total clinical efficacy was 61.9% and 86.7% respectively.No patients died. CONCLUSION: Lumbrokinase plus aspirin can be used for secondary prevention of ischemic stroke.It is safe and well-tolerated and may be of great clinical value.

About this research paper

What this paper is about

AIM: To assess the prophylactic effect of lumbrokinase plus aspirin on recurrence of ischemic stroke in the patients recovering from cerebral infarction. METHODS: 87 patients of cerebral infarction were assigned to two groups:control and treatment group,treated respectively with aspirin in control group and lumbrokinase plus aspirin in the treatment group.The recurrence rate and clinical efficacy were analysed. RESULTS: There were remarkable differences in recurrence rate and clinical efficacy between the two groups(P0.05).The recurrence rate was(11.9%) in the control group and 4.4% in the treatment group.The total clinical efficacy was 61.9% and 86.7% respectively.No patients died. CONCLUSION: Lumbrokinase plus aspirin can be used for secondary prevention of ischemic stroke.It is safe and well-tolerated and may be of great clinical value.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

AIM: To assess the prophylactic effect of lumbrokinase plus aspirin on recurrence of ischemic stroke in the patients recovering from cerebral infarction. METHODS: 87 patients of cerebral infarction were assigned to two groups:control and treatment group,treated respectively with aspirin in control group and lumbrokinase plus aspirin in the treatment group.The recurrence rate and clinical efficacy were analysed. RESULTS: There were remarkable differences in recurrence rate and clinical efficacy between the two groups(P0.05).The recurrence rate was(11.9%) in the control group and 4.4% in the treatment group.The total clinical efficacy was 61.9% and 86.7% respectively.No patients died. CONCLUSION: Lumbrokinase plus aspirin can be used for secondary prevention of ischemic stroke.It is safe and well-tolerated and may be of great clinical value.

Key concepts: Medicine, Aspirin, Internal medicine, Clinical efficacy, Brain infarction, Cerebral infarction, Ischemic stroke, Stroke (engine)

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
The prophylactic effect of lumbrokinase plus aspirin on recurrence of ischemic stroke in the patients — Research Paper | ScholarLens